Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

RepliCel Life Sciences (RP)

RepliCel Life Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:RP
DateTimeSourceHeadlineSymbolCompany
08/05/202413:14PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - RPTSXV:RPRepliCel Life Sciences Inc
08/05/202413:11PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - RPTSXV:RPRepliCel Life Sciences Inc
29/11/202304:48PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RPRepliCel Life Sciences Inc
05/01/202302:04PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RPRepliCel Life Sciences Inc
23/12/201911:00PR Newswire (Canada)RepliCel Announces its Incoming Board of DirectorsTSXV:RPRepliCel Life Sciences Inc
26/11/201911:00PR Newswire (Canada)RepliCel Provides 2019 Year-End UpdateTSXV:RPRepliCel Life Sciences Inc
24/09/201911:00PR Newswire (Canada)Clinical Data Published from RepliCel's Skin Rejuvenation StudyTSXV:RPRepliCel Life Sciences Inc
10/09/201911:00PR Newswire (Canada)RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in ChinaTSXV:RPRepliCel Life Sciences Inc
29/08/201911:00PR Newswire (Canada)RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Auto...TSXV:RPRepliCel Life Sciences Inc
16/04/201911:00PR Newswire (Canada)RepliCel Secures Several New Patents for its Regenerative Medicine TechnologiesTSXV:RPRepliCel Life Sciences Inc
26/03/201910:00PR Newswire (Canada)RepliCel's Licensee Building Momentum in China with Facility and TeamTSXV:RPRepliCel Life Sciences Inc
19/03/201910:00PR Newswire (Canada)RepliCel Reignites its First-in-Japan StrategyTSXV:RPRepliCel Life Sciences Inc
05/03/201911:00PR Newswire (Canada)RepliCel CEO Provides 2019 Shareholder UpdateTSXV:RPRepliCel Life Sciences Inc
06/11/201811:00PR Newswire (Canada)RepliCel Life Sciences Appoints Head of Clinical and Regulatory AffairsTSXV:RPRepliCel Life Sciences Inc
18/10/201811:00PR Newswire (Canada)RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, CanadaTSXV:RPRepliCel Life Sciences Inc
17/10/201811:00PR Newswire (Canada)RepliCel Life Sciences Appoints New Chief Financial OfficerTSXV:RPRepliCel Life Sciences Inc
15/10/201811:00PR Newswire (Canada)RepliCel CEO Provides Updated OutlookTSXV:RPRepliCel Life Sciences Inc
11/10/201811:00PR Newswire (Canada)RepliCel Life Sciences Completes Financing with YOFOTO (China) HealthTSXV:RPRepliCel Life Sciences Inc
24/09/201811:00PR Newswire (Canada)RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete InvestmentTSXV:RPRepliCel Life Sciences Inc
11/07/201811:00PR Newswire (Canada)RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater ChinaTSXV:RPRepliCel Life Sciences Inc
02/05/201811:00PR Newswire (Canada)RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTOTSXV:RPRepliCel Life Sciences Inc
25/01/201811:00PR Newswire (Canada)RepliCel CEO Provides 2018 Shareholder UpdateTSXV:RPRepliCel Life Sciences Inc
16/01/201811:00PR Newswire (Canada)RepliCel Life Sciences Lands Commitment for Key Investment PartnershipTSXV:RPRepliCel Life Sciences Inc
19/10/201722:00PR Newswire (Canada)RepliCel Life Sciences Successfully Closes FinancingTSXV:RPRepliCel Life Sciences Inc
23/09/201701:24PR Newswire (Canada)RepliCel Retains Hybrid Financial for Investor RelationsTSXV:RPRepliCel Life Sciences Inc
13/09/201711:00PR Newswire (Canada)RepliCel's Partnership Initiatives Mature into Licensing NegotiationsTSXV:RPRepliCel Life Sciences Inc
07/09/201711:00PR Newswire (Canada)RepliCel Showcases First Fully-Functional Prototypes of its Next-Generation Dermal InjectorTSXV:RPRepliCel Life Sciences Inc
10/08/201711:00PR Newswire (Canada)Prominent Skin Aging Researcher Provides Insights into RepliCel's Clinical DataTSXV:RPRepliCel Life Sciences Inc
13/06/201711:00PR Newswire (Canada)RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data MapTSXV:RPRepliCel Life Sciences Inc
25/05/201711:00PR Newswire (Canada)RepliCel CEO Provides Company OutlookTSXV:RPRepliCel Life Sciences Inc
 Showing the most relevant articles for your search:TSXV:RP